Shadow

Archive for the ‘Uncategorized’ Category

Updated: Possible Product Launches for 2011

Product Anticipated Ship Date Brand Sales Additional information Caduet  11/30/2011 $340 million Ranbaxy will have a license to sell generic version Caduet in the U.S. effective November 30, 2011,  Concerta 5/1/2011 $989 million Watson can start selling its version on May 1. Johnson & Johnson will supply Watson with the drug and receive a share [...]

Possible Product Launches for 2011

Product Anticipated Ship Date Brand Sales Additional information Caduet  11/30/2011 $340 million Ranbaxy will have a license to sell generic version Caduet in the U.S. effective November 30, 2011,  Femara 6/3/2011 $533 million Mylan settled, can market before the patent expires  Levaquin 6/20/2011 $1.5 billion Teva has been granted final approval and first-to-file status for [...]

Hard to Find Products – In Stock

Budesonide .50 inhal Gabapentin 600mg Mirtazapine Nitrofurantoin Mono 100mg Quelicin Topiramate Sprinkles

Product Issues and Anticipated Ship Dates

Azetazolamide ER 500mg -  3/31 Budesonide Inhal Sol -  under allocation Epidrin – Under allocation Leflunomide -  4/22 Lithium Carb ER 450mg – TBD Mebendazole – 3/15 Metronidazole -  2/18 Orphenadrine/ASA/Caff – TBD Oxcarbazepine Susp – Week of 2/1 Paroxetine ER 12.5mg – TBD Sucralfate -  partial release 2/4 Tamiflu Suspension – TBD

Plavix gets extension on U.S. market exclusivity

BOSTON (MarketWatch) — In a move that had been widely expected, Bristol-Myers Squibb (NYSE:BMY) and partner Sanofi-Aventis (NYSE:SNY) announced that they have been given a six-month extension on U.S. market exclusivity for their blockbuster blood-thinner Plavix. U.S. regulators granted the extension after the companies agreed to run certain pediatric studies with the drug. Plavix, one [...]

FDA Drug Safety Communication: Prescription Acetaminophen Products to be Limited to 325 mg Per Dosage Unit; Boxed Warning Will Highlight Potential for Severe Liver Failure

The U.S. Food and Drug Administration (FDA) is asking drug manufacturers to limit the strength of acetaminophen in prescription drug products, which are predominantly combinations of acetaminophen and opioids. This action will limit the amount of acetaminophen in these products to 325 mg per tablet, capsule, or other dosage unit, making these products safer for [...]

Now Available in Generic

Amerge Arimidex Astelin Augmentin XR Differin Cream Differin Gel Effexor XR Exelon Lovenox Skelaxin Tarka Tussionex Yaz

New Generics Now Available – 2010

Now Available in Generic from Capital Drug *Aldara 2-25 *Ambien CR 6.25mg 10-14 *Amerge 7-8 *Arimidex 6-28 *Astelin 6-23 *Augmentin XR 5-17 *Cardizem LA 3-15 *Cozaar 4-8 Diastat 9-1 *Differin Gel 6-2 *Effexor XR 7-1 *Exelon 7-1 *Flomax 3-2 *Hyzaar 4-8 *Lovenox 7-23 Methylin 7-28 *Mirapex 1-4 *Prevacid Solutab 10-18 *Prozac Weekly 3-23 Sanctura 8-16 [...]

Hard to find In Stock

Budesonide Estradiol .5mg, 2mg Estrafied Estrogen/Methyltestosterone Fluticasone Hydrocortisone Tabs Lithium Carb ER 450mg Medroxyprogesterone 150mg/ml Mirtazapine Nitrofurantoin Mono Promethazine Inj. Testosterone Cypionate 200mg/ml Trazodone

Product Issues and Anticipated Ship Dates

Acetazolamide ER 500mg — 12/1 Budesonide .5mg  – under allocation Clomipramine 50mg, 75mg  -  12/15 Desmopressin NS — under allocation Estradiol — partial release 10/29. Fluphenazine Inj.— Long term b/o Fluticasone — under allocation Guanabenz 8mg  -  11/30 Haloperidol Inj — November Haloperidol Sol — partial release 10/29 Hydromorphone Inj — 2/24/11 Methazolamide — 11/15 [...]